PROBLEMS AND PROSPECTS OF OPTIMAL MANAGEMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH ACUTE CORONARY SYNDROME AND MYOCARDIAL INFARCTION
DOI:
https://doi.org/10.11603/1811-2471.2022.v.i4.13491Keywords:
arterial hypertension, acute coronary syndrome, myocardial infarction, target blood pressure levelsAbstract
SUMMARY. Arterial hypertension (AH) is one of the main risk factors for acute coronary syndrome (ACS) and myocardial infarction (MI). From a clinical perspective, blood pressure (BP) should be closely monitored in patients with acute coronary syndrome for many reasons, primarily to prevent further target organ damage and complications. However, there is currently no single point of view regarding the target BP levels in certain categories of patients in different phases of recovery treatment of myocardial infarction.
Hypertension in the anamnesis of patients with myocardial infarction is most associated with a worse prognosis. In contrast, some studies have suggested that increased systolic blood pressure in the acute phase of MI has a compensatory and protective effect and is associated with lower 1-year mortality from coronary occlusion. Therefore, the search for optimal programs for the management of arterial hypertension in patients with acute coronary syndrome and myocardial infarction is currently an urgent and promising task.
References
Van de Werf, F., Bax, J., Betriu, A., Blomstrom-Lundqvist, C., Crea, F., ... & Rutten, F. (2008). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. European Heart Journal, 29(23), 2909-2945.
World Health Organization (2011). Global atlas on cardiovascular disease prevention and control: published by the World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization. World Health Organization. Regional Office for Europe. Retrieved from: http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/. Accessed August 12, 2014.
Collet, J.P., & Thiele, H. (2020). The ‘Ten Commandments’ for the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., ... & Desormais, I. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). European Heart Journal, 39(33), 3021-3104.
Reinstadler, S.J., Eitel, C., Thieme, M., Metzler, B., Poess, J., Desch, S., ... & Eitel, I. (2016). Comparison of characteristics of patients aged ≤45 years versus >45 years with ST-elevation myocardial infarction (from the AIDA STEMI CMR substudy). The American Journal of Cardiology, 117(9), 1411-1416.
Izzo, J.L., & Gradman, A.H. (2004). Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure. Medical Clinics, 88(5), 1257-1271.
Blood Pressure Lowering Treatment Trialists' Collaboration. (2000). Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. The Lancet, 356(9246), 1955-1964.
Dumaine, R., Gibson, C.M., Murphy, S.A., Southard, M., Ly, H.Q., McCabe, C.H., ... & Braunwald, E. (2006). Association of a history of systemic hypertension with mortality, thrombotic, and bleeding complications following non-ST-segment elevation acute coronary syndrome. The Journal of Clinical Hypertension, 8(5), 315-322.
Levytska, L.V. (2019). Functional characteristics of patients with myocardial infarction with concomitant diseases of peripheral arteries and peculiarities of approachest otheir rehabilitation treatment. Zdobutky klinichnoyi i eksperymentalnoyi medytsyny – Achievements of Clinical and Experimental Medicine, 1(37), 17–22
Pedrinelli, R., Ballo, P., Fiorentini, C., Denti, S., Galderisi, M., Ganau, A., ... & Zacà, V. (2012). Hypertension and acute myocardial infarction: an overview. Journal of Cardiovascular Medicine, 13(3), 194-202.
Sola, M., Venkatesh, K., Caughey, M., Rayson, R., Dai, X., Stouffer, G. A., & Yeung, M. (2017). Ratio of systolic blood pressure to left ventricular end-diastolic pressure at the time of primary percutaneous coronary intervention predicts in-hospital mortality in patients with ST-elevation myocardial infarction. Catheterization and Cardiovascular Interventions, 90(3), 389-395.
De Luca, G., Parodi, G., Sciagrà, R., Bellandi, B., Comito, V., Vergara, R., ... & Antoniucci, D. (2013). Impact of hypertension on infarct size in ST elevation myocardial infarction patients undergoing primary angioplasty. Journal of Hypertension, 31(12), 2433-2437.
Lingman, M., Herlitz, J., Bergfeldt, L., Karlsson, T., Caidahl, K., & Hartford, M. (2009). Acute coronary syndromes–the prognostic impact of hypertension, diabetes and its combination on long-term outcome. International Journal of Cardiology, 137(1), 29-36.
Roth, D., Van Tulder, R., Heidinger, B., Herkner, H., Schreiber, W., & Havel, C. (2015). Admission blood pressure and 1-year mortality in acute myocardial infarction. International Journal of Clinical Practice, 69(8), 812-819.
Lee, D., Goodman, S.G., Fox, K.A., DeYoung, J.P., Lai, C.C., Bhatt, D.L., ... & Yan, A.T. (2013). Prognostic significance of presenting blood pressure in non–ST-segment elevation acute coronary syndrome in relation to prior history of hypertension. American Heart Journal, 166(4), 716-722.
Lawes, C.M., Vander Hoorn, S., & Rodgers, A. (2008). Global burden of blood-pressure-related disease, 2001. The Lancet, 371(9623), 1513-1518.
Rosendorff, C., Black, H.R., Cannon, C.P., Gersh B.J., Gore, J., & Izzo, J.L. (2007). American Heart Association Council for High Blood Pressure Research; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation, 115(21), 2761-2788.
Shved, M.I., & Levytska, L.V. (2018). Approaches to the assessment of risks and functional reserves of the cardiovascular system in patients with myocardial infarction with comorbid pathology, who are in the acute period of cardio-rehabilitation. World of Medicine and Biology, 4(66), 124-130.
Levytska, L., Shved, M., & Korda, M. (2019). Estimation of functional reserves of the body and risk of cardiovascular events in patients with myocardial infarction with comorbid pathology undergoing rehabilitation. Health Problems of Civilization, 13(3), 178-186.
Levytska, L.V. (2019). Early marker and limited factors of fuctional state in patients with myocardial infarction in combination with arterial hypertension. Visnyk naukovykh doslidzhen – Herald of Scientific Research, (1), 33-38.
Bhatt, D.L., Lopes, R.D., & Harrington, R.A. (2022). Diagnosis and treatment of acute coronary syndromes: a review. JAMA, 327(7), 662-675.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Achievements of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
